Hybrid Cell Membrane‐Engineered Nanocarrier for Triple‐Action Strategy to Address Pseudomonas aeruginosa Infection DOI Creative Commons

Shunhao Zhang,

Tianyu Chen, Weitong Lu

и другие.

Advanced Science, Год журнала: 2024, Номер unknown

Опубликована: Дек. 25, 2024

Bacterial infections resistant to antimicrobial treatments, particularly those caused by Pseudomonas aeruginosa (P. aeruginosa), frequently lead elevated mortality rates. Tackling this resistance using therapeutic combinations with varied mechanisms has shown considerable promise. In study, a bioinspired nanocarrier is successfully designed and engineered for targeted antibiotic delivery toxin/bacteria clearance. This achieved encapsulating antibiotic-loaded framework nucleic acids hybrid cell membranes acquired from neutrophils platelets. By coating the membrane outside shell, nanocarriers are endowed function of neutrophil-like chemotaxis platelet-like bacteria adhesion achieve first stage inflammation targeting. Based on specific binding toxin membrane, release triggered toxin-mediated lysis fulfill second neutralization killing. Meanwhile, immunomodulation potential enables accomplish third reversing immunosuppressive microenvironment. mouse models acute chronic P. pneumonia, can reduce bacterial burden at low dosage decrease negligible toxicity. sum, these findings have illustrated remarkable capability in treating recalcitrant infections.

Язык: Английский

Current Understanding and Translational Prospects of Tetrahedral Framework Nucleic Acids DOI Creative Commons
Junjie Gu,

Jiale Liang,

Taoran Tian

и другие.

JACS Au, Год журнала: 2025, Номер 5(2), С. 486 - 520

Опубликована: Фев. 10, 2025

Tetrahedral framework nucleic acids (tFNAs) represent a promising advancement in acid nanotechnology due to their unique structural properties, high biocompatibility, and multifaceted biomedical applications. Constructed through one-pot annealing method, four single-stranded DNAs self-assemble into stable, three-dimensional tetrahedral nanostructures with enhanced mechanical robustness physiological stability, resisting enzymatic degradation. Their ability permeate mammalian cells without transfection agents, coupled modifiable surfaces, positions tFNAs as versatile carriers for drug gene delivery systems. The tFNA-based platforms exhibit superior therapeutic efficacy, including antioxidative anti-inflammatory effects, alongside efficient cellular uptake tissue penetration. These features underpin role precision medicine, enabling targeted of diverse agents such synthetic compounds, peptides, acids. Additionally, demonstrate significant potential regenerative immune modulation, antibacterial strategies, oncology. By addressing challenges translational integration, stand poised accelerate the development research clinical applications, fostering novel therapies enhancing outcomes across wide spectrum diseases. This Perspective thoroughly details attributes applications critically evaluates tFNAs' potential, outlining inherent implementation exploring solutions these obstacles.

Язык: Английский

Процитировано

2

Advancements in Functional Tetrahedral DNA Nanostructures for Multi-biomarker Biosensing: Applications in Disease Diagnosis, Food Safety, and Environmental Monitoring DOI Creative Commons
Yunping Qiu, Yixing Qiu,

Wenchao Zhou

и другие.

Materials Today Bio, Год журнала: 2025, Номер 31, С. 101486 - 101486

Опубликована: Янв. 21, 2025

Язык: Английский

Процитировано

0

Circular Single‐Stranded DNA‐Based Artificial Nanoviruses Mitigate Colorectal Cancer Development DOI Open Access
Jinghao Wang, Pengfei Zhang,

Yonglian Huang

и другие.

Small Methods, Год журнала: 2025, Номер unknown

Опубликована: Янв. 21, 2025

Abstract Colorectal cancer (CRC) remains a significant global health challenge, underscoring the need for innovative therapeutic strategies. Oncogenic miRNAs (oncomiRs) play biological role in initiation and progression of colorectal cancer. Inspired by cooperative mechanisms plant nanovirus, which employ multiple circular single‐stranded DNA (CssDNA) genomes, it is hypothesized that development delivery CssDNA to target oncomiRs would achieve benefits CRC. In this study, multi‐omics approach utilized identify key tumor suppressor genes (TSGs) their related implicated CRC, followed CssDNA, each loaded with miRNA binding sites targeting one oncomiR. When transfected into cells, these can effectively sequester corresponding restore expression TSGs, leading marked reduction CRC both vitro vivo. The findings highlight potential nanovirus‐inspired modulating miRNA‐mediated regulatory network This study lays groundwork non‐coding DNA‐based therapies broad implications treatment potentially other malignancies.

Язык: Английский

Процитировано

0

Tetrahedral Framework Nucleic Acid Relieves Sepsis‐Induced Intestinal Injury by Regulating M2 Macrophages DOI Creative Commons

Tingting Tan,

Jiajie Li,

Wensi Fan

и другие.

Cell Proliferation, Год журнала: 2025, Номер unknown

Опубликована: Янв. 22, 2025

ABSTRACT This study aimed to clarify the role and mechanism of tetrahedral framework nucleic acids (tFNAs) in regulating M2 macrophages reduce intestinal injury. An injury model was established by intraperitoneal injection lipopolysaccharides (LPS) mice explore alleviating effects tFNAs on Inflammatory factors were detected quantitative polymerase chain reaction (qPCR) enzyme‐linked immunosorbent assay (ELISA). The barrier permeability assessed using western blotting immunohistochemistry. Macrophages gut localised quantified immunofluorescence. Western used investigate inflammation injured intestines. These results show that attenuated sepsis‐induced can also promote reconstruction permeability. In vivo, accelerated aggregation at an early stage reduced number M1 intestine. addition, enhanced clearance ability macrophages. They activated signalling transcription activating factor 1(STAT1) cytokine inhibitory 1/3 (SOCS1/3) pathways increasing expression phagocytic receptor Mertk. findings indicated alleviate macrophages, providing a new option for treating

Язык: Английский

Процитировано

0

Nanoparticles encapsulating antigenic peptides induce tolerogenic dendritic cells in situ for treating systemic lupus erythematosus DOI
Xin Qin, Mei Zhang,

Jiale Liang

и другие.

Journal of Controlled Release, Год журнала: 2025, Номер 380, С. 943 - 956

Опубликована: Фев. 21, 2025

Язык: Английский

Процитировано

0

Tetrahedral-DNA-Nanostructure-Modified Engineered Extracellular Vesicles Enhance Oral Squamous Cell Carcinomas Therapy by Targeting GPX4 DOI
Dianri Wang, Yun Wang, Sicheng Zhang

и другие.

ACS Nano, Год журнала: 2025, Номер unknown

Опубликована: Фев. 27, 2025

Oral squamous cell carcinoma (OSCC) represents a heterogeneous group of malignancies originating from the mucosal lining oral cavity. Current treatment modalities primarily involve surgery, chemotherapy, and radiotherapy. Despite use multimodal therapy, 5 year overall survival rate for OSCC remains around 50%, underscoring need development nontoxic agents with potent antitumor activity. Extracellular vesicles (EVs) are nanoscale, membrane-bound structures that can selectively deliver small molecules, nucleic acids, proteins to target cells, making them promising platform drug delivery in cancer therapy. Strategies improve uptake EVs enhance therapeutic molecules cells critical advancing precision medicine. Tetrahedral DNA nanostructures (TDNs) have shown significant potential facilitating endocytosis delivery, as well improving tissue penetration. In this study, TDN@EVs were conducted by modifying membrane surface M1-EVs TDNs, which demonstrated improved biological stability efficiency compared unmodified EVs. vitro vivo experiments showed significantly inhibited proliferation migration while promoting apoptosis. exhibited superior penetration properties, further amplifying their effects. Proteomic analysis identified Hsc70 key protein responsible activity TDN@EVs. The efficient into tumor led degradation GPX4, inducing ferroptosis, mitochondrial stress, damage cells. These findings highlight an effective safe approach conclusion, present strategy targeted treatment, offering enhanced stability,

Язык: Английский

Процитировано

0

Tetrahedral DNA nanostructure based siRNA delivery vehicle for braf gene silencing and MEK-ERK pathway inhibition in the treatment of refractory thyroid cancer DOI
Sicheng Zhang, Yun Wang, Dianri Wang

и другие.

Nano Today, Год журнала: 2025, Номер 62, С. 102694 - 102694

Опубликована: Фев. 28, 2025

Язык: Английский

Процитировано

0

Treatment of atherosclerosis by biomimetic responsive-targeting hybrid nanoparticles enabled by genetically engineering cell membranes and nucleic acid nanostructures for atorvastatin delivery DOI
Tianyu Chen,

Weitong Lv,

Mengxi Yang

и другие.

Chemical Engineering Journal, Год журнала: 2025, Номер unknown, С. 162130 - 162130

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Smart nucleic acid nanodrug delivery system for precision therapeutics DOI
Yu Chen,

Zongkang Guo,

Jing Li

и другие.

Coordination Chemistry Reviews, Год журнала: 2025, Номер 535, С. 216673 - 216673

Опубликована: Апрель 3, 2025

Язык: Английский

Процитировано

0

Treatment of rheumatoid arthritis via tetrahedral framework nucleic acid‑based efficient delivery of Jakinib: Synergistic anti-inflammatory and osteogenic effects DOI

Yichen Yang,

Ruiqing Wang,

Wumeng Yin

и другие.

Chemical Engineering Journal, Год журнала: 2025, Номер unknown, С. 162405 - 162405

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0